Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension.
about
New insights into the role of soluble guanylate cyclase in blood pressure regulationThe role of phosphodiesterase inhibitors in the management of pulmonary vascular diseasesA molecular mechanism for therapeutic effects of cGMP-elevating agents in pulmonary arterial hypertension.Icariin Inhibits Pulmonary Hypertension Induced by Monocrotaline through Enhancement of NO/cGMP Signaling Pathway in Rats.Regulation of Pulmonary Vascular Smooth Muscle Contractility in Pulmonary Arterial Hypertension: Implications for Therapy.
P2860
Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension.
@en
type
label
Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension.
@en
prefLabel
Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension.
@en
P2093
P1476
Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension.
@en
P2093
Chien-nien Chen
Geoffrey Watson
P304
P356
10.1016/J.VPH.2012.09.001
P577
2012-09-12T00:00:00Z